May 18, 2022 / NTS GMT
Presentation
May 18, 2022 / NTS GMT
=====================
Corporate Participants
=====================
* René C. Goehrum
BioSyent Inc. - Chairman, CEO & President
=====================
RenéC. Goehrum - BioSyent Inc. - Chairman, CEO & President
Hello. Welcome to the BioSyent Inc. Q1 2022 Results Presentation. My name is René Goehrum, and I'm the President and CEO of the company.
I want to draw your attention to our disclaimer on forward-looking statements. And let's jump into the presentation with a look at our sales, EBITDA and net income after tax.
So this slide shows you first quarter ending March 31 of '22 and compares it to '21 and 2020. So a few things I'd like to point out.
Our sales were down 5% from the year ago quarter but flat when comparing only to continued operations. So you'll recall we announced midway through the year last year that we would be rationalizing our product portfolio and discontinuing certain products. We have taken that step and now those discontinued products no longer
Q1 2022 Biosyent Inc Earnings Presentation Transcript
May 18, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers